2026-10-25
Perimeter Solutions, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,990 +1.35%
S&P 7,377 +0.31%
GOLD $4,075 −0.94%
BTC $75,727 −0.03%
VIX 25.64 −9.01%
latest tape · as of 18:05 UTC
The Screen · Basic Materials · Specialty Chemicals
Perimeter Solutions, Inc.
PRM · the NYSE · USD · Market cap $4.6B · 356 employees
Perimeter Solutions, Inc.
Not yet scored29.50 USD
Price as of 6 Nov 2026Daily close, not a live quote
Screened 2026-11-06 · the tape above runs as of 18:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price29.50 USD at the 6 Nov 2026 close
- Our value readFair vs our fair value, as of 6 Nov 2026
- Our regime readMarkdown, as of 7 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 1.38)
- Last reviewed6 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $27.73 to $31.89, base estimate $27.73 (screen dated 2026-11-06).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.38, read 2026-11-05
- Ethical screen not yet scored
Price29.50 USD
Fair value27.73
Ethical score70.0/100
Value readFairas of 6 Nov 2026
Our investment reviews on this name
2026-11-01Read Accumulation28.06+5.1% to today ✓Markdown gives way to Accumulation
2026-10-21Read Markdown27.07+9.0% to today Distribution gives way to Markdown first Markdown read since September
2026-10-02Read Distribution27.20+8.5% to today Markdown gives way to Distribution after a 13% slide in 3 weeks
2026-09-10Read Markdown31.30-5.8% to today ✓Markup gives way to Markdown after a 12% slide in 10 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
Perimeter Solutions, Inc. holds its Markdown at $29.50. The statistical read favours the buyers, held for 4 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 4 days |
| Price at the screen | $29.50 |
| Valuation | N/A trailing · 15.35 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.90 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 26.65% | Below 33% | Interest-bearing debt is just 26.7% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 14.71% | Below 49% | Money owed to the company is 14.7% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Perimeter Solutions, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Perimeter Solutions, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Fair vs our fair value, as of 6 Nov 2026: it trades above our $27.73 fair value estimate, 31.50% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. The price runs 6.4% above the base estimate.
Third-party analyst targets: 4 covering, consensus Buy. The average target sits +36% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $27.73, with a range of $27.73 to $31.89, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWildfire boom hides a classic cyclical trap
Picture a wildfire season that doubles orders overnight. Perimeter Solutions rides that surge with 74% revenue growth, yet still posts a 27% negative profit margin and negative 16% return on equity. The forward multiple of 18.2 times earnings sits above our fair value, and the cyclical nature of firefighting demand makes the headline number look more like peak earnings than a bargain.
We pass because the business shows no durable edge and the numbers already signal the trap. Revenue can vanish as fast as it appears when seasons calm or budgets tighten, leaving a thin margin structure exposed. Analyst targets sit higher, yet the gap between price and our calculated value leaves no margin of safety.
Currency swings and commodity costs add further volatility on top of the ethical pass. Analysis, not advice.
| Forward P/E | 15.3xcheap for a company growing this fast |
| EPS, trailing | -2.23 |
| EPS, forward | 1.83 |
| Revenue growth | +31.5%strong top-line growth |
| Profit margin | -44.9%currently unprofitable |
| Return on equity | -30.9%not currently earning a positive return on equity |
| FCF yield | 1.30% |
| Debt to equity | 1.35a meaningful debt load worth watching |
| Current ratio | 1.57healthy short-term liquidity |
| Beta | 1.90much more volatile than the market |
| Short interest, float | 0.06% |
| 52-week range | 20.38 - 38.17 |
| Market cap | $4.6B |
| Employees | 356 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePRM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-05
Accumulation $28.10
-1.5% Entry 18
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04
Accumulation $28.54
+1.7% Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03
Accumulation $28.06
+0.0% Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Accumulation $28.06
+0.0% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Accumulation · changed $28.06
+0.9% Entry 14
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Markdown $27.80
+0.0% Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Markdown $27.80
+0.0% Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Markdown $27.80
+2.7% Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23
Markdown $27.07
+0.0% Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22
Markdown $27.07
+0.0% Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 154%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (2 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- International Flavors to Report Q3 Earnings: What's in the Offing? Yahoo Finance · 8d ago
- Eastman Chemical Q3 Earnings Miss Estimates Despite Higher Pricing Yahoo Finance · 8d ago
- Bunge Ready to Report Q3 Earnings: What's in Store for the Stock? Yahoo Finance · 11d ago
- Does Perimeter Solutions, SA (PRM) Have the Potential to Rally 38.79% as Wall Street Analysts Expect? Yahoo Finance · 11d ago
- SHW Q3 Earnings Lag Estimates on Higher Costs, Sales Beat Yahoo Finance · 11d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
CLMTCalumet, Inc.
CBTCabot Corporation
AVNTAvient Corporation
BCPCBalchem Corporation
SXTSensient Technologies Corporation
ASHAshland Inc.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $32.16 | +4.9% | · | $1,049 | +4.9% |
| 2 months | $25.48 | +32.3% | · | $1,323 | +32.3% |
| 3 months | $23.05 | +46.3% | · | $1,463 | +46.3% |
| 6 months | $28.78 | +17.2% | · | $1,172 | +17.2% |
| 1 year | $13.30 | +153.5% | · | $2,535 | +153.5% |
| 2 years | $7.18 | +369.6% | · | $4,696 | +369.6% |
| 3 years | $6.52 | +417.2% | · | $5,172 | +417.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PRM does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.